leafie leafie
  • Cannabis
  • Psychedelics
  • Culture
  • Health
  • Shop
    • Bookshop
    • Apparel & Merch
    • Magazine
      • Issue 02
      • Issue 01
  • Membership
  • My Account
  • About leafie
  • Contact Us

advertisement

7K
4K
3K
0

Input your search keywords and press Enter.

leafie leafie
leafie leafie
  • Cannabis
  • Psychedelics
  • Culture
  • Health
  • Shop
    • Bookshop
    • Apparel & Merch
    • Magazine
      • Issue 02
      • Issue 01
woman holding neck in pain as symptom of fibromyalgia
  • Health

Ketamine could provide long-term pain relief for people with fibromyalgia

A study of 92 women with fibromyalgia found “substantial and sustained” pain relief among patients treated with repeated intravenous ketamine infusions.
  • Kevin Dinneen
  • October 5, 2026
  • 3 minute read

A study examining the role ketamine could play in treating pain associated with fibromyalgia found that median pain scores among a cohort of 92 women fell from eight out of ten to five out of ten after three months, with significant pain relief maintained among patients who responded to treatment for up to 24 months.

The study, published in the Journal of Pain Research, was conducted in the USA by a team from the Carolinas Pain Institute. The team described how repeated ketamine infusions were associated with “substantial and sustained” reductions in pain over the 24-month study period.

Fibromyalgia is a long-term condition characterised by widespread pain and increased sensitivity to pain, alongside symptoms that can include severe fatigue, disrupted sleep, muscle stiffness, depression and problems with memory and concentration, often referred to as “fibro-fog”. Symptoms vary from person to person and can have a significant impact on day-to-day life.

Treatment options currently available to people living with the condition can include exercise, talking therapies and medications including antidepressants and painkillers. The effectiveness of these treatments varies between patients, while some medications can cause significant unwanted side effects, leading to interest in alternative approaches to managing chronic pain associated with fibromyalgia.

Ketamine has been studied extensively over the past two decades for its pain-relieving qualities. It reduces pain through a mechanism that involves blocking N-methyl-D-aspartate (NMDA) receptors in the brain. It is thought to be particularly useful for reducing pain associated with fibromyalgia because NMDA receptors are involved in central sensitisation, a process in which the nervous system becomes increasingly sensitive to pain signals.

The 92 women included in the study were aged between 24 and 78, with a median age of 49. Patients reported an average of two additional chronic pain conditions, while 33 were taking opioids when they began ketamine treatment.

The treatment protocol consisted of three initial infusions administered no more than one week apart, followed by further infusions as required every three to ten months, with a median interval of six months. Some patients discontinued treatment before completing the initial three infusions.

Each session lasted around three hours, with patients receiving between 300mg and 500mg of ketamine. They were also given between 3mg and 6mg of the sedative midazolam to reduce hallucinations associated with ketamine’s dissociative effects.

After three months, 32 of the 92 women reported reductions in pain of more than 50%. Thirty were still reporting pain relief of more than 50% after 24 months.

However, the treatment did not benefit everyone. Nineteen patients reported minimal or no improvement, including seven who received only one infusion, six who received two and six who completed three.

Among patients who responded to ketamine, the duration of pain relief varied but averaged around six months. The researchers said the length of relief experienced by individual patients also tended to remain relatively consistent between treatments.

Side effects were reported by 19 patients and were generally described as mild. Nausea was the most common, affecting 12 patients, while ten experienced hallucinations despite receiving midazolam. No serious adverse events were reported.

The study has several important limitations. It was a retrospective study with no control group, meaning the results cannot establish that ketamine itself caused the reductions in pain.

Ketamine was also used alongside patients’ existing treatments, with numerous changes made to other medications during the 24-month follow-up. The researchers acknowledged that this makes it difficult to determine whether improvements were caused by ketamine, changes to other treatments or a combination of the two.

Despite these limitations, the researchers say the study is the largest retrospective analysis to examine the long-term effects of repeated ketamine infusions in people with severe fibromyalgia. They concluded that the results warrant a large, prospective randomised trial to investigate the treatment further.

0
0

Share
Tweet
Share
Share
Share
Share
Kevin Dinneen

Kevin is leafie's cofounder and head of the news desk. He is passionate about cannabis, the countryside and fish and chips.

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • leafie magazine issue 2 front coverAdd to basket

    The leafie Magazine – Issue 02

    £13.00
  • Pipe Dreams and Smoke Screens book by Richard Halford coverAdd to basket

    Pipe Dreams and Smoke Screens: A Memoir of Hashish Adventures in the Sixties

    £8.50
  • single pack of leafie own brand king size slim rolling papersAdd to basket

    leafie King Size Slim Organic Rolling Papers

    £2.00
  • picture of the front cver of a book titled 'Weed: Adventures of a dope smuggler' by Jerry KamstraAdd to basket

    Weed: Adventures of a Dope Smuggler – Jerry Kamstra (1974) (First Edition)

    £50.00

Follow Our News Channels

Follow us on Apple NewsFollow us on Google News

advertisement

Latest News

  • The Tunnug 1 archaeological excavation site in southern Siberia.
    • Cannabis
    People were getting high on cannabis 2,800 years ago, research suggests
    • Liam O'Dowd
    • November 6, 2026
  • medical cannabis close up
    • Cannabis
    Police appeal for witnesses after armed robbery of medical cannabis
    • Liam O'Dowd
    • November 5, 2026
  • Woman holding vial of THCa cannabinoid in lab bottle
    • Cannabis
    THCA and HHC set for ban under new cannabis crackdown
    • Kevin Dinneen
    • November 4, 2026

advertisement

Recent Articles

  • mans hand holding bag of powder cocaine
    • Health
    Britain’s drug deaths have fallen, but thousands are still dying
    • Liam O'Dowd
    • November 4, 2026
  • microscope closeup looking for medical cannabis evidence research concept
    • Cannabis
    Eight years of medical cannabis in the UK. Where is the evidence now?
    • Dr Simon Erridge
    • November 3, 2026
  • swiss flag flying in basel, home of weed care pilot
    • Cannabis
    Legal cannabis linked to reductions in depression, anxiety and problematic use
    • Liam O'Dowd
    • November 2, 2026

advertisement

Join team leafie

Sign up for our newsletter and get the best of our articles delivered to your inbox.

Be first in line for free leafie merch, discounts and competitions. No spam, ever. Pinky promise.

Related Articles

mans hand holding bag of powder cocaine
Read More
  • Health

Britain’s drug deaths have fallen, but thousands are still dying

  • Liam O'Dowd
  • November 4, 2026
un expert prof ben saul
Read More
  • Health

UN expert calls for legal regulation of drugs

  • Kevin Dinneen
  • October 26, 2026
young adult couple smoking cannabis in relaxed environment
Read More
  • Health

Irish committee recommends decriminalisation of all drugs for personal use

  • Liam O'Dowd
  • June 24, 2026
mp jeremy corbyn in house of commons
Read More
  • Health

Cross-party MPs call for urgent repeal of UK drug laws as deaths hit record high

  • Liam O'Dowd
  • June 9, 2026
Close-up of aged female eye
Read More
  • Health

What chronic stress actually does to skin, sleep and recovery

  • leafie
  • May 21, 2026
hand holding unlit cigarette
Read More
  • Health

Is the UK’s smoking ban set to fail?

  • Liam O'Dowd
  • May 6, 2026
selective focus shot of toilet
Read More
  • Health

Ketamine use up, MDMA use down latest wastewater analysis shows

  • Kevin Dinneen
  • March 20, 2026
man holding mdma pills in open hand
Read More
  • Health

The Loop launches London’s first drug checking service

  • Liam O'Dowd
  • March 10, 2026
keir starmer
Read More
  • Health

Law enforcement organisation criticises Starmer over attacks on drug reform

  • Liam O'Dowd
  • February 25, 2026
woman with chronic neck pain sat at desk
Read More
  • Health

One in four adults in England living with chronic pain, NHS data shows

  • Liam O'Dowd
  • January 28, 2026
leafie logo
  • Articles
  • Cannabis
  • Psychedelics
  • Culture
  • Health
  • Magazine
  • Membership
  • Login / Register
  • About us
  • Contact us
  • Advertise on leafie
  • Terms & Conditions
  • WRITE FOR US
IMPRESS-Regulated-Member-Trustmark_White_RGB-e1676641595807.png
CIC_member.png
Instagram Facebook X-twitter Linkedin

© LEAFIE LIMITED 2026. All rights reserved. LEAFIE is a registered trademark of LEAFIE LIMITED. 

  • Disclaimer
  • Complaints
  • Privacy Policy